Clearwater Analytics Gains As Investors Eye Growth Beyond Acquisition Jitters
1. CWAN shares rose 3.55% amid acquisition concerns. 2. Goldman Sachs upgraded CWAN to Buy with a $27 target. 3. Analyst foresees 20% growth from new products and automation. 4. Rate cuts may enhance CWAN's revenue linked to asset pricing. 5. Enfusion integration could yield 19% total growth by 2027.